Skip to main content
72°
Mostly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about JNJ
Recent news which mentions JNJ
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
32
33
Next >
What Analysts Are Saying About Johnson & Johnson Stock
October 10, 2024
Tickers
JNJ
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
Insights Into Johnson & Johnson's Performance Versus Peers In Pharmaceuticals Sector
October 10, 2024
Tickers
JNJ
NEWS
Tags
JNJ
Market News
BZI/IA
From
Benzinga
1 Vanguard Index Fund Could Turn $500 Per Month Into a $968,400 Portfolio That Pays $16,000 in Annual Dividend Income
October 09, 2024
Tickers
AAPL
AVGO
JNJ
JPM
Tags
AVGO
MSFT
JPM
From
Motley Fool
What To Expect When Johnson & Johnson Reports Q3 Earnings Next Week?
October 08, 2024
Tickers
JNJ
NEWS
Tags
Market News
Briefs
JNJ
From
Benzinga
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
October 04, 2024
Tickers
JNJ
NEWS
TAK
Tags
General
TAK
Top Stories
From
Benzinga
2 Smart Income Stocks to Buy Right Now
October 04, 2024
Tickers
JNJ
KO
Tags
JNJ
Recent Press Releases
Market News
From
Motley Fool
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
October 02, 2024
Tickers
JNJ
Tags
JNJ
Markets
Options
From
Benzinga
Johnson & Johnson's Erleada Shows Improved Overall Survival In Prostate Cancer Patients Compared To Pfizer's Drug
October 02, 2024
Tickers
JNJ
NEWS
PFE
Tags
Stories That Matter
Biotech
Market News
From
Benzinga
Johnson & Johnson/ Legend Biotech Partnered Blood Cancer Drug Extends Overall Survival, Support Use In Previously Treated Patients
September 30, 2024
Tickers
JNJ
LEGN
NEWS
Tags
Health Care
Analyst Color
Large Cap
From
Benzinga
2 Excellent Dividend Stocks to Buy With Less Than $200
September 28, 2024
Tickers
ABT
JNJ
Tags
ABT
Market News
Recent Press Releases
From
Motley Fool
Johnson & Johnson Reports Updated Data From Two Early-Stage Multiple Myeloma Studies Of Talvey Combo Treatment
September 27, 2024
Tickers
JNJ
NEWS
Tags
Market News
Stories That Matter
Biotech
From
Benzinga
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
September 26, 2024
Tickers
JNJ
NEWS
Tags
News
Trading Ideas
Benzinga
From
Benzinga
Why Masimo Stock Crushed the Market Today
September 25, 2024
Tickers
JNJ
KFY
MASI
Tags
JNJ
Recent Press Releases
MASI
From
Motley Fool
Private Equity Firms Circle Sanofi's Consumer Health Business Amid Potential Spinoff
September 25, 2024
Tickers
GS
GSK
HLN
JNJ
Tags
Benzinga
Top Stories
Media
From
Benzinga
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
September 25, 2024
Tickers
ABT
JNJ
Tags
ABT
Market News
JNJ
From
Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Tickers
BHVN
BMY
BNTX
CI
Tags
VKTX
BZI/AUOA
Benzinga
From
Benzinga
Is Johnson & Johnson Stock a Buy?
September 21, 2024
Tickers
JNJ
Tags
Market News
Recent Press Releases
JNJ
From
Motley Fool
Johnson & Johnson's Rybrevant Scores Third FDA-Approval Of 2024 For Certain Type Of Inoperable Lung Cancer In Pretreated Patients
September 20, 2024
Tickers
JNJ
NEWS
Tags
Equities
Market News
JNJ
From
Benzinga
Zevra Therapeutics' Drug Becomes First FDA-Approved Treatment For Ultra-Rare Neurodegenerative Disease
September 20, 2024
Tickers
JNJ
NEWS
ZVRA
Tags
Top Stories
Benzinga
General
From
Benzinga
The Latest Analyst Ratings For Johnson & Johnson
September 19, 2024
Tickers
JNJ
Tags
BZI/AAR
Analyst Ratings
Market News
From
Benzinga
2 Vanguard Index Funds Could Turn $400 Per Month Into $16,800 in Annual Dividend Income by Retirement
September 19, 2024
Tickers
AAPL
AMZN
AVGO
GOOG
Tags
GOOGL
JNJ
PG
From
Motley Fool
Chinese Biotech BeiGene Labeled 'Unique Investment' As Analyst Confident In Lead Cancer Drug
September 18, 2024
Tickers
AZN
BGNE
JNJ
NEWS
Tags
Large Cap
News
Health Care
From
Benzinga
Should You Buy Novavax Stock After This Regulatory Win?
September 13, 2024
Tickers
BNTX
JNJ
MRNA
NVAX
Tags
Market News
BNTX
JNJ
From
Motley Fool
Unpacking the Latest Options Trading Trends in Johnson & Johnson
September 12, 2024
Tickers
JNJ
Tags
Benzinga
BZI/UOA
JNJ
From
Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
September 12, 2024
Tickers
JNJ
NEWS
Tags
Market News
BZI/IA
Markets
From
Benzinga
How To Earn $500 A Month From Johnson & Johnson Stock
September 12, 2024
Tickers
JNJ
NEWS
Tags
Earnings
dividend yield
Benzinga
From
Benzinga
Metals in Tampons: FDA Initiates New Safety Measures and Testing
September 11, 2024
Tickers
EPC
JNJ
KMB
NEWS
Tags
AI Generated
Stories That Matter
FDA
From
Benzinga
Sony Music-Universal Music JV Hits Johnson & Johnson With Copyright Lawsuit Over Unlicensed Music Use Covering 80 Videos
September 11, 2024
Tickers
JNJ
NEWS
Tags
Biotech
AI Generated
Stories That Matter
From
Benzinga
Johnson & Johnson's Mid-Stage Lung Cancer Trial Reveals Fewer Infusion-Related Reactions
September 11, 2024
Tickers
JNJ
NEWS
Tags
Health Care
Benzinga
Top Stories
From
Benzinga
Is Hims & Hers Health the Next Teladoc?
September 11, 2024
Tickers
HIMS
JNJ
LLY
MRNA
Tags
NVO
Market News
HIMS
From
Motley Fool
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.